RIG
61
6
CMS
61
-3
LB
49
-14
MLM
58
4
XRAY
46
2
ECL
62
2
FMC
34
-2
FLS
75
2
ISRG
73
2
TXN
45
2
EXR
64
-2
NVDA
54
2
PFE
28
2
URBN
76
10
AVB
65
-2
TROW
59
-3
VRSN
59
-4
SO
62
-2
VTR
50
-5
ROK
56
-7
RIG
61
6
CMS
61
-3
LB
49
-14
MLM
58
4
XRAY
46
2
ECL
62
2
FMC
34
-2
FLS
75
2
ISRG
73
2
TXN
45
2
EXR
64
-2
NVDA
54
2
PFE
28
2
URBN
76
10
AVB
65
-2
TROW
59
-3
VRSN
59
-4
SO
62
-2
VTR
50
-5
ROK
56
-7
Financhill
Back

Matthews Emerging Markets Ex Chn Act ETF Vs. Bright Minds Biosciences Industry Stock Comparison

Buy
51

MEMX
Matthews Emerging Markets Ex Chn Act ETF

Last Price:
29.70
Seasonality Move:
8.2%
Sell
25

DRUG
Bright Minds Biosciences

Last Price:
46.84
Seasonality Move:
-15.89%
Buy
51
Matthews Emerging Markets Ex Chn Act ETF (MEMX) is a Buy

Is Matthews Emerging Markets Ex Chn Act ETF a Buy, Sell or Hold?

  • The current Matthews Emerging Markets Ex Chn Act ETF [MEMX] share price is $29.70. The Score for MEMX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • MEMX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $44.00. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MEMX Stock Price Chart

What is Matthews Emerging Markets Ex Chn Act ETF's stock price today?

  • The Matthews Emerging Markets Ex Chn Act ETF share price today is $29.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MEMX is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $44.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.

MEMX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 42.05 Sell
Chaikin Money Flow: 523 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.61 - 30.37) Sell
Bollinger Bands (100): (29.68 - 30.9) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.5 Buy
Relative Strength Index (14 RSI): 58.93 Buy
Chaikin Money Flow: 115403 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.12 - 49.42) Buy
Bollinger Bands (100): (-5.11 - 34.85) Buy

MEMX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.81 Sell
20-day SMA: 29.87 Sell
50-day SMA: 30.38 Sell
200-day SMA: 29.72 Sell
8-day EMA: 29.79 Sell
20-day EMA: 29.91 Sell
50-day EMA: 30.15 Sell
200-day EMA: 29.53 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.17 Buy
20-day SMA: 42.3 Buy
50-day SMA: 28.61 Buy
200-day SMA: 8.06 Buy
8-day EMA: 39.27 Buy
20-day EMA: 39.13 Buy
50-day EMA: 31.07 Buy
200-day EMA: 12.97 Buy

Matthews Emerging Markets Ex Chn Act ETF Earnings Growth & MEMX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Matthews Emerging Markets Ex Chn Act ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):